ENTITY
Neuren Pharmaceuticals

Neuren Pharmaceuticals (NEU AU)

60
Analysis
Health CareAustralia
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company. The Company researches neurological and metabolic disorders.
more
bullishPolyNovo Ltd
15 Mar 2023 07:03

Australia: S&P/​ASX, REMX, GDXJ, MVA, MVW, Other Flows on Friday

Implementation of the S&P/ASX, REMX, GDXJ, MVA and other indices take place at the close on Friday. There will be a lot of passive flow going...

Logo
555 Views
Share
bullishBellevue Gold
06 Mar 2023 04:18

OZ Minerals (OZL AU): Scheme Meeting in April; Potential S&P/ASX Changes

OZL's acquisition by BHP is nearly a done deal. Passive trackers will sell 18.24m shs (A$509m; 9.6x ADV) of OZL on the last trading day. There will...

Logo
585 Views
Share
09 Sep 2022 08:00Issuer-paid

Neuren Pharmaceuticals Ltd - On the Cusp of Commercialisation

Neuren Pharmaceuticals Ltd On the cusp of commercialisation Neuren Pharmaceuticals Ltd (ASX:NEU) is a clinical-stage drug company focused...

Share
04 Sep 2022 22:04

S&P ASX Sep 22 Rebal: Decent Impacts but Avoid Short Buildup

The Top 10 ADDs & DELs have average impacts of +12.7 and -11.2 days to trade respectively. Some DELs names have significant short buildup.

Share
03 Sep 2022 07:01

S&P/​​ASX Index Rebalance (Sep 2022): Adds, Deletes, Surprises & Pre-Positioning

There are a lot of changes to the ASX200 and ASX300 indices with high impact. There are a few surprises, mainly in the ASX300. Shorts have surged...

Logo
708 Views
Share
x